Increased intravascular platelet activity in metabolic syndrome patients, and its correction by simvastatin treatment
Simvastatin treatment in patients with arterial hypertension (AH) and metabolic syndrome (MS) corrects dyslipoproteinemia, peroxidation syndrome, and optimizes platelet homeostasis. Simvastatin inhibits increased intravascular platelet activity in vivo. For stable correction of metabolism and platel...
Saved in:
Main Authors: | N. I. Gromnatsky, I. N. Medvedev, B. M. Golikov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2004-12-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/2312 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CORRECTION OF AGGREGATIVE FUNCTION OF THE TROMBOCYTES IN ARTERIAL HYPERTENSION PATIENTS WITH METABOLIC SYNDROM UNDER THE INFLUENCE OF SIMVASTATINE
by: N. J. Gromnazky, et al.
Published: (2003-12-01) -
Intravascular platelet activity correction by fosinopril in arterial hypertension patients with metabolic syndrome
by: I. N. Medvedev, et al.
Published: (2006-10-01) -
Eprosartan effects on intravascular platelet activity in patients with arterial hypertension and metabolic syndrome
by: I. N. Medvedev, et al.
Published: (2008-02-01) -
PLATELET HEMOSTASIS DYNAMICS IN SIMVASTATINTREATED PATIENTS WITH ARTERIAL HYPERTENSION AND DYSLIPIDEMIA
by: I. N. Medvedev, et al.
Published: (2010-02-01) -
Nebivolol therapy and reduction of intravascular platelet activity in patients with atrial hypertension and metabolic syndrome
by: I. N. Medvedev
Published: (2006-06-01)